Article
Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening
9 Oct 2023
Abstract excerpt
Abstract Developing therapeutic antibodies is laborious and costly. Here we report a method for antibody discovery that leverages the Illumina HiSeq platform to, within 3 days, screen in the order of 10 8 antibody–antigen interactions. The method, which we named ‘deep screening’, involves the clustering and sequencing of antibody libraries, the conversion of the DNA clusters into complementary RNA clusters...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
